Abstract:Epidermal keratinocytes synthesize and secrete α‐melanocyte stimulating hormone (α‐MSH) and adrenocorticotropic hormone (ACTH). These act as agonists of the melanocortin 1 receptor expressed on the cell surface of human melanocytes. Binding of these physiological agonists or synthetic α‐MSH analogs to human MC1R activates the cAMP pathway, leading to activation of transcription factors, mainly p53, MITF, and Nrf2. The downstream targets of these transcription factors enhance DNA repair and antioxidant capacities, promote melanocyte survival, and increase eumelanin synthesis. These pleotropic effects confer photoprotection and prevent vitiligo. The physiological role of α‐melanocyte stimulating hormone in regulating integumental pigmentation of many vertebrate species has been recognized since the 1960's. However, its physiological significance for human pigmentation remained enigmatic until the 1990's. α‐Melanocyte stimulating hormone and related melanocortins are synthesized locally in the skin, primarily by keratinocytes, in addition to the pituitary gland, and therefore act as paracrine factors for melanocytes. Human melanocytes express the melanocortin 1 receptor, which recognizes α‐melanocyte stimulating hormone and the related adrenocorticotropic hormone as agonists. This review summarizes the current knowledge of the pleotropic effects of the activated melanocortin 1 receptor that maintain human melanocyte homeostasis by regulating melanogenesis and the response to environmental stressors, mainly solar radiation. Certain allelic variants of the melanocortin 1 receptor gene are associated with specific pigmentary phenotypes in various human populations. Variants associated with red hair phenotype compromise the function of the encoded receptor. Activation of the human melanocortin 1 receptor regulates eumelanin synthesis and enhances DNA damage response of melanocytes to solar radiation and oxidative stressors. We describe how synthetic selective melanocortin 1 receptor agonists can be efficacious as sunless tanning agents, for treatment of vitiligo and photosensitivity disorders, and for prevention of skin cancer, including melanoma.

Synthesis and Pharmacological Characterization of Adrenocorticotropic Hormone (ACTH 1–24) and C-Terminal Truncated Analogues Identifies the Minimal ACTH N-Terminal Fragment Required for Melanocorton-2 Receptor Activation

Identification of antagonists for melanocortin MC3, MC4 and MC5 receptors

The Proopiomelanocortin System

Replacement of short segments within transmembrane domains of MC2R disrupts retention signal

Journey through the spectacular landscape of melanocortin 1 receptor

Mechanism of N-terminal modulation of activity at the melanocortin-4 receptor GPCR

Molecular signatures of human melanocortin receptors for ligand binding and signaling

Structural basis of signaling regulation of the human melanocortin-2 receptor by MRAP1

Analogs of alpha-melanocyte stimulating hormone with high agonist potency and selectivity at human melanocortin receptor 1b: the role of Trp(9) in molecular recognition

Effects of melanocortin receptor ligands on thyrotropin-releasing hormone release: evidence for the differential roles of melanocortin 3 and 4 receptors

Chimeric NDP-MSH and MTII melanocortin peptides with agouti-related protein (AGRP) Arg-Phe-Phe amino acids possess agonist melanocortin receptor activity

A review of melanocortin receptor small molecule ligands

Desacetyl-α-melanocyte stimulating hormone and α-melanocyte stimulating hormone are required to regulate energy balance

The Effect of ACTH/MSH N-Terminal Fragment Analogs on the Anxiety Level, Pain Sensitivity and Levels of Neurotrophic Factors BDNF and VEGF in Primary Neuronal Cultures of Rats

[Regulation of appetite by melanocortin and its receptors]

Interaction of the melanocortin 2 receptor with nucleoporin 50: evidence for a novel pathway between a G-protein-coupled receptor and the nucleus

Structural mechanism of calcium-mediated hormone recognition and Gβ interaction by the human melanocortin-1 receptor

Chimeras of the agouti-related protein: insights into agonist and antagonist selectivity of melanocortin receptors

Protein Tyrosine Phosphatase Receptors N and N2 Control Pituitary Melanotroph Development and POMC Expression

Recommended Tool Compounds for the Melanocortin Receptor (MCR) G Protein-Coupled Receptors (GPCRs)

Structural insights into ligand recognition and subtype selectivity of the human melanocortin-3 and melanocortin-5 receptors